AU750909B2 - Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage - Google Patents
Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage Download PDFInfo
- Publication number
- AU750909B2 AU750909B2 AU29791/99A AU2979199A AU750909B2 AU 750909 B2 AU750909 B2 AU 750909B2 AU 29791/99 A AU29791/99 A AU 29791/99A AU 2979199 A AU2979199 A AU 2979199A AU 750909 B2 AU750909 B2 AU 750909B2
- Authority
- AU
- Australia
- Prior art keywords
- composition
- desmethylselegiline
- selegiline
- moles
- liter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7804398P | 1998-03-16 | 1998-03-16 | |
US60/078043 | 1998-03-16 | ||
PCT/US1999/004588 WO1999047133A1 (en) | 1998-03-16 | 1999-03-03 | Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2979199A AU2979199A (en) | 1999-10-11 |
AU750909B2 true AU750909B2 (en) | 2002-08-01 |
Family
ID=22141568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU29791/99A Ceased AU750909B2 (en) | 1998-03-16 | 1999-03-03 | Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage |
Country Status (13)
Country | Link |
---|---|
US (3) | US6461619B1 (de) |
EP (1) | EP1063981B1 (de) |
CN (1) | CN1154484C (de) |
AT (1) | ATE222101T1 (de) |
AU (1) | AU750909B2 (de) |
BR (1) | BR9908713A (de) |
CA (1) | CA2322878C (de) |
DE (1) | DE69902520T2 (de) |
DK (1) | DK1063981T3 (de) |
ES (1) | ES2178405T3 (de) |
HK (1) | HK1037980A1 (de) |
IL (2) | IL138290A0 (de) |
WO (1) | WO1999047133A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6033682A (en) | 1995-01-13 | 2000-03-07 | Somerset Pharmaceuticals, Inc. | S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions |
DE69902520T2 (de) | 1998-03-16 | 2003-04-10 | Somerset Pharmaceuticals Inc | Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden |
AU2001286798B2 (en) * | 2000-08-28 | 2007-05-17 | Somerset Pharmaceuticals, Inc. | Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions |
FR2813195B1 (fr) * | 2000-08-29 | 2003-04-04 | Serobiologiques Lab Sa | Utilisation d'extraits de la plante cassia alata dans des produits de soin |
AU2002357311A1 (en) * | 2001-12-18 | 2003-06-30 | Johns Hopkins University School Of Medicine | Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes |
DE10229456A1 (de) * | 2002-07-01 | 2004-02-05 | Wank, Rudolf, Prof. Dr.med. | Verwendung von Dopamin-Rezeptor-Agonisten zur Behandlung von Hautgeschwülsten und Warzen |
US20050276762A1 (en) * | 2004-06-15 | 2005-12-15 | Tapas Das | Topical compositions containing 5'-adenosine-diphosphate ribose |
KR101329907B1 (ko) * | 2005-04-28 | 2013-11-14 | 가부시키가이샤 나노에그 | 경피 흡수 촉진제 |
EP1731143B1 (de) * | 2005-06-06 | 2008-11-26 | Nitto Denko Corporation | Pharmazeutische Zusammensetzung zur perkutane Absorption unter Verwendung von einem Metalchlorid, vorzugsweise Natriumchlorid, zur Vorbeugung von Kohäsionsschwäche |
US20090324693A1 (en) * | 2008-06-30 | 2009-12-31 | Kimberly-Clark Worldwide, Inc. | Delivery Product for Topical Compositions |
MX2013004214A (es) | 2010-10-15 | 2013-06-05 | Procter & Gamble | Uso de inhibidores de monoamina oxidasa para mejorar la biologia epitelial. |
WO2012082950A2 (en) * | 2010-12-14 | 2012-06-21 | University Of Rochester | Chimeric fibronectin matrix mimetics and uses thereof |
US9539201B2 (en) | 2012-04-20 | 2017-01-10 | KAT Transdermals LLC | Selegiline transdermal system |
IT201800006455A1 (it) * | 2018-06-19 | 2019-12-19 | Nuovo utilizzo degli inibitori della monoammino ossidasi B |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1192495A (en) * | 1993-11-30 | 1995-06-19 | Jean-Hilaire Saurat | Use of selegiline and its derivatives for the treatment of psoriasis |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3764144D1 (de) | 1986-04-16 | 1990-09-13 | Asta Pharma Ag | Synergistische kombination von amantadin und selegilin. |
ATE76747T1 (de) | 1986-06-10 | 1992-06-15 | Chiesi Farma Spa | Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen. |
US4861800A (en) | 1987-08-18 | 1989-08-29 | Buyske Donald A | Method for administering the drug deprenyl so as to minimize the danger of side effects |
US4868218A (en) | 1987-08-18 | 1989-09-19 | Buyske Donald A | Method of treating depression |
US5446070A (en) | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
GB8807504D0 (en) | 1988-03-29 | 1988-05-05 | Sandoz Ltd | Improvements in/relating to organic compounds |
US4959205A (en) * | 1989-03-23 | 1990-09-25 | Collagen Corporation | Composition and method for treatment of dermal inflammation |
US5221536A (en) | 1990-05-07 | 1993-06-22 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
US5190763A (en) | 1990-05-07 | 1993-03-02 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
US5192550A (en) | 1990-05-07 | 1993-03-09 | Alza Corporation | Dosage form for treating central nervous system disorders |
US5057321A (en) | 1990-06-13 | 1991-10-15 | Alza Corporation | Dosage form comprising drug and maltodextrin |
US5128145A (en) | 1990-06-13 | 1992-07-07 | Alza Corporation | Dosage form for Parkinson's disease, spasticity and muscle spasms |
CA2039194C (en) | 1990-08-31 | 1997-01-28 | Norton W. Milgram | Uses of l-deprenyl and compositions for same |
US5783606A (en) * | 1995-02-10 | 1998-07-21 | The University Of Toronto Innovations Foundation | Deprenyl compounds for treatment of glaucoma |
HU209605B (en) | 1991-04-15 | 1994-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for production of wather-free transdermal preparation |
US5266332A (en) | 1991-12-06 | 1993-11-30 | Alza Corporation | Method for administering anti-Parkinson drug |
EP0593807A1 (de) | 1992-10-22 | 1994-04-27 | LTS Lohmann Therapie-Systeme GmbH & Co. KG | Transdermales Pflaster zur Abgabe von basischen, flüchtigen pharmazeutischen Wirkstoffen und Verfahren zu ihrer Herstellung |
US5242950A (en) | 1992-04-23 | 1993-09-07 | Somerset Pharmaceuticals, Inc. | Treatment of macular degeneration |
US5354885A (en) | 1992-12-24 | 1994-10-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Process for preparing ethyl ester of L-DOPA |
FR2728790B1 (fr) * | 1994-12-29 | 1997-01-24 | Cird Galderma | Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial |
WO1996022068A2 (en) * | 1995-01-13 | 1996-07-25 | Somerset Pharmaceuticals, Inc. | Methods and pharmaceutical compositions employing desmethylselegiline |
WO1997033572A1 (en) * | 1996-03-15 | 1997-09-18 | Somerset Pharmaceuticals, Inc. | Method for preventing and treating peripheral neurophathy by administering selegiline |
US6262111B1 (en) * | 1997-05-21 | 2001-07-17 | Sloan-Kettering Institute For Cancer Research | Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
US20020006913A1 (en) * | 1997-11-04 | 2002-01-17 | Von Borstel Reid W. | Antimutagenic compositions for treatment and prevention of photodamage to skin |
DE69902520T2 (de) * | 1998-03-16 | 2003-04-10 | Somerset Pharmaceuticals Inc | Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden |
-
1999
- 1999-03-03 DE DE69902520T patent/DE69902520T2/de not_active Expired - Fee Related
- 1999-03-03 DK DK99911055T patent/DK1063981T3/da active
- 1999-03-03 WO PCT/US1999/004588 patent/WO1999047133A1/en active IP Right Grant
- 1999-03-03 AT AT99911055T patent/ATE222101T1/de not_active IP Right Cessation
- 1999-03-03 CA CA002322878A patent/CA2322878C/en not_active Expired - Lifetime
- 1999-03-03 EP EP99911055A patent/EP1063981B1/de not_active Expired - Lifetime
- 1999-03-03 CN CNB998060755A patent/CN1154484C/zh not_active Expired - Fee Related
- 1999-03-03 ES ES99911055T patent/ES2178405T3/es not_active Expired - Lifetime
- 1999-03-03 IL IL13829099A patent/IL138290A0/xx unknown
- 1999-03-03 BR BR9908713-8A patent/BR9908713A/pt not_active Application Discontinuation
- 1999-03-03 AU AU29791/99A patent/AU750909B2/en not_active Ceased
-
2000
- 2000-09-06 IL IL138290A patent/IL138290A/en not_active IP Right Cessation
- 2000-09-15 US US09/663,218 patent/US6461619B1/en not_active Expired - Fee Related
-
2001
- 2001-12-20 HK HK01108942A patent/HK1037980A1/xx not_active IP Right Cessation
-
2002
- 2002-08-08 US US10/215,492 patent/US6709664B2/en not_active Expired - Fee Related
-
2004
- 2004-03-23 US US10/806,494 patent/US7147864B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1192495A (en) * | 1993-11-30 | 1995-06-19 | Jean-Hilaire Saurat | Use of selegiline and its derivatives for the treatment of psoriasis |
Also Published As
Publication number | Publication date |
---|---|
ES2178405T3 (es) | 2002-12-16 |
EP1063981A1 (de) | 2001-01-03 |
CA2322878C (en) | 2008-05-06 |
CN1154484C (zh) | 2004-06-23 |
BR9908713A (pt) | 2000-11-21 |
CN1300209A (zh) | 2001-06-20 |
US6709664B2 (en) | 2004-03-23 |
US20030021833A1 (en) | 2003-01-30 |
WO1999047133A1 (en) | 1999-09-23 |
DE69902520D1 (de) | 2002-09-19 |
ATE222101T1 (de) | 2002-08-15 |
US6461619B1 (en) | 2002-10-08 |
AU2979199A (en) | 1999-10-11 |
DK1063981T3 (da) | 2002-10-14 |
HK1037980A1 (en) | 2002-03-01 |
US20040180009A1 (en) | 2004-09-16 |
DE69902520T2 (de) | 2003-04-10 |
EP1063981B1 (de) | 2002-08-14 |
IL138290A (en) | 2010-05-17 |
IL138290A0 (en) | 2001-10-31 |
US7147864B2 (en) | 2006-12-12 |
CA2322878A1 (en) | 1999-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU750909B2 (en) | Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage | |
AU769604B2 (en) | Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors | |
US6030974A (en) | Method of anesthesia | |
JP4987209B2 (ja) | 瘢痕形成作用を有する医薬品を製造するためのビグアニド誘導体の使用 | |
WO1995005813A1 (en) | COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID | |
JPH01501143A (ja) | 爪への薬物の施用のための皮膜形成性製剤用ヴェヒクル、これらのヴェヒクルを基にした薬剤組成物および同じものの使用法 | |
CA2194876A1 (en) | Bioadhesive-wound healing composition | |
CN115300508A (zh) | 包含孟鲁司特与贻贝粘附蛋白的组合的局部制剂 | |
US6821523B2 (en) | Topical administration of pharmacologically active bases in the treatment of warts | |
JPH06500708A (ja) | 薬物の改良されたイオン導入法による投与 | |
JP2011001373A (ja) | 傷の治癒、火傷のショックの治療、アテローム性動脈硬化症、器官移植、鬱病、精神分裂病、及び化粧品におけるラムノリピドの使用 | |
AU2002317053A1 (en) | Dermal therapy using phosphate derivatives of electron transfer agents | |
WO2003011303A1 (en) | Dermal therapy using phosphate derivatives of electron transfer agents | |
EP0822816B1 (de) | Dermatologische zubereitung zur behandlung von aktinischen keratosen | |
JP2002505295A (ja) | 局所抗ウイルス組成物として組み合わせた無機亜硝酸塩及び有機酸 | |
US6479533B1 (en) | Methods and compositions for the protection of mitochondria | |
EP3586926B1 (de) | Zusammensetzungen und verfahren zur behandlung von hauterkrankungen unter verwendung von licht und glucosaminhydrochlorid | |
US6174541B1 (en) | Skin aging and wound treatment using cell migration agents | |
Rampen | Hypertrichosis in PUVA‐treated patients | |
MXPA00009098A (en) | Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage | |
US20040022868A1 (en) | Compositions using tetrasilver tetroxide and methods for management of skin conditions using same | |
JPH03500656A (ja) | ウイルス感染の治療および予防薬剤アシル・カルニチン | |
KR20140107389A (ko) | 상피의 관통 및 세포의 생물학적 이용률을 증가시키도록 화학적으로 개질된 광역학적 치료용 조성물 | |
WO1995034262A1 (en) | Transdermal treatment of malaria | |
US5994399A (en) | Method of regenerating collagen-containing tissues with misoprostol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |